Centurium takes control of China's Luckin Coffee
Centurium Capital is now the controlling shareholder in Luckin Coffee, having teamed up with IDG Capital and Ares SSG to take out interests formerly owned by executives of the scandal-hit Chinese coffee shop chain.
The 383.4m class A ordinary shares – held by entities under the control of Zhengyao Lu and Zhiya Qian, Luckin’s ex-chairman and CEO, respectively, and their families – were ordered to be wound up...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.